# Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)

> **NCT01597973** · PHASE3 · COMPLETED · sponsor: **University of Michigan** · enrollment: 467 (actual)

## Conditions studied

- Pneumonia
- Blood Stream Infection

## Interventions

- **DRUG:** colistin and meropenem
- **DRUG:** colistin and placebo

## Key facts

- **NCT ID:** NCT01597973
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10-06
- **Primary completion:** 2020-08-09
- **Final completion:** 2020-08-09
- **Target enrollment:** 467 (ACTUAL)
- **Last updated:** 2022-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01597973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01597973, "Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01597973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*